Novavax (NVAX) Receivables (2010 - 2026)
Novavax (NVAX) recorded Receivables of $22.84 million in Q2 2026, down 90.1% from $231.7 million a year earlier and down 17.0% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Receivables (2010 - 2026) Analysis & Trends
At the end of FY2025, Novavax reported Receivables of $117.25 million, up 3.1% from FY2024.
- Annual Receivables has a five-year compound annual growth rate of -14.9% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $113.69 million in FY2024 (-63.1%), $308.04 million in FY2023 (+177.6%), $110.98 million in FY2022 (-77.4%) and $490.29 million in FY2021 (+87.1%).
- The Q2 2026 figure is the lowest quarterly Receivables since Q1 2024.
- On a year-over-year basis, Receivables rose in three of the last eight quarters, with growth averaging 51.1%.
- Peak year-over-year performance for Receivables in the last five years was growth of 790.0% in Q3 2021, against a decline of 92.4% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $27.51 million (Q1 2026), $117.25 million (Q4 2025) and $39.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,159.18 Bn | 1,127.77 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 624.72 Bn | 543.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 511.45 Bn | 484.56 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 366.25 Bn | 320.63 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.73 Bn | 261.72 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.55 Bn | 235.23 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 234.97 Bn | 190.37 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.23 Bn | 168.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.56 Bn | 118.20 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Novavax | 1.83 Bn | -1.17 Bn | 42.45 Mn | 22.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.84 Mn |
| Mar 31, 2026 | 27.51 Mn |
| Dec 31, 2025 | 117.25 Mn |
| Sep 30, 2025 | 39.37 Mn |
| Jun 30, 2025 | 231.70 Mn |
| Mar 31, 2025 | 50.61 Mn |
| Dec 31, 2024 | 113.69 Mn |
| Sep 30, 2024 | 101.16 Mn |
| Jun 30, 2024 | 34.41 Mn |
| Mar 31, 2024 | 21.58 Mn |
| Dec 31, 2023 | 308.04 Mn |
| Sep 30, 2023 | 176.26 Mn |
| Jun 30, 2023 | 455.39 Mn |
| Mar 31, 2023 | 155.55 Mn |
| Dec 31, 2022 | 110.98 Mn |
| Sep 30, 2022 | 179.65 Mn |
| Jun 30, 2022 | 223.53 Mn |
| Mar 31, 2022 | 530.46 Mn |
| Dec 31, 2021 | 490.29 Mn |
| Sep 30, 2021 | 109.96 Mn |
API Access
Novavax Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();